Loading organizations...
Loading organizations...
Blink Health: Technology platform providing discounted prescription medications online for consumers, focused on affordable drug access.
Blink Health has raised $165.0M across 2 funding rounds.
Key people at Blink Health.
Blink Health has raised $165.0M in total across 2 funding rounds.
Blink Health is a healthcare technology platform headquartered in New York that enables consumers to purchase prescription medications online at discounted prices for local pharmacy pickup. The company aggregates patient purchasing power to negotiate lower drug prices, offering discounts of up to 90 percent off average retail costs regardless of a user's insurance status. Users can access these negotiated rates through free iOS and Android mobile applications or a web portal, with prescriptions available for fulfillment at a network of more than 57,000 participating pharmacies nationwide. To support its operations and expansion within the opaque pharmaceutical supply chain, the enterprise has secured $165 million in total venture capital funding. This capitalization includes a $90 million Series B financing round led by the venture capital firm 8VC. Blink Health was founded in 2014 by Geoffrey Chaiken.
Blink Health is a digital health company founded in 2015 that builds technology platforms to make prescription medications accessible and affordable for everyone.[1][2][3] It offers two primary products—BlinkRx and Quick Save—which provide discounted prescription drugs, online doctor visits for select conditions, transparent pricing, pickup at 35,000+ pharmacies, and home delivery, targeting patients frustrated by high drug costs and supply chain barriers.[1][2][5][8] Serving millions across the U.S., Blink solves the prescription pricing crisis by negotiating lower prices and streamlining access, with around 278-282 employees and headquarters in New York, NY.[1][3] The company has shown strong growth through multiple funding rounds, including a Series D led by 1789 Capital, positioning it as a leader in the online pharmacy space.[1]
Blink Health was founded in 2015 by brothers Geoffrey Chaiken and Matthew Chaiken, who identified the U.S. drug pricing crisis as a "burning car on the side of the highway" and launched a tech-driven solution to make prescriptions affordable.[1][4] Early traction came from angel investments, including from entrepreneur Scott Belsky, followed by a Series A to enhance the product and a 2019 growth equity round from Deerfield Management.[1][5] Pivotal moments include expanding to online doctor visits, home delivery, and a Series D funding round with 1789 Capital, where Donald Trump Jr. joined the board to guide expansion amid rapid scaling in the digital pharmacy sector.[1]
Blink Health rides the digital health and telepharmacy trend, capitalizing on post-pandemic demand for convenient, affordable care amid soaring U.S. drug prices and opaque pricing.[1][2][4] Timing aligns with regulatory shifts enabling online pharmacies and consumer shift to tech platforms, amplified by investor backing from VCs like 8VC and 1789 Capital to scale nationwide.[1][7] Market forces favoring Blink include rising generic drug adoption, supply chain disruptions from traditional players, and payer frustrations, positioning it to influence the ecosystem by pressuring incumbents like Walgreens on pricing and expanding access in underserved areas.[8]
Blink Health is poised for further dominance in digital pharmacies through tech innovation, geographic expansion, and board expertise like Donald Trump Jr.'s strategic input.[1] Trends like AI-driven personalization, broader telehealth integration, and value-based care will shape its path, potentially capturing more market share as drug costs rise and consumers demand transparency. Its influence may evolve by partnering with insurers and payers, redefining prescription access and driving industry-wide affordability—echoing its founding mission to remove every obstacle between people and life-changing medications.[2][4]
Blink Health has raised $165.0M in total across 2 funding rounds.
Blink Health's investors include Joe Lonsdale, Friedom Partners.
Key people at Blink Health.
Blink Health has raised $165.0M across 2 funding rounds. Most recently, it raised $90.0M Series B in April 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 12, 2017 | $90.0M Series B | Joe Lonsdale | |
| Apr 1, 2016 | $75.0M Series A | Friedom Partners |
